AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
The American Association for Cancer Research (AACR) and its 47,000 member scientists and physicians are unified in a strong desire...
Members of the LGBTQ community face staggering rates of discrimination in the United States. According to data from the...
Editor’s note: As President Joseph R. Biden Jr. took office on Wednesday, Cancer Discovery, a journal of the American...
Guest Post by William G. Nelson, MD, PhDEditor-in-Chief, Cancer Today Clearly, cancers that have metastasized, or spread, to many different...
2020 was filled with unexpected challenges for cancer research and patient care. As many of us shifted our lives...
In the early 1970s, German virologist Harald zur Hausen, MD, FAACR, defied the dogma that cervical cancer was caused by the herpes simplex...
As the year draws to a close, we bring you the final edition of Editors’ Picks for 2020. This monthly roundup features one “must read” article, handpicked by...
This month, the Early Detection Research Network (EDRN) marks its 20th anniversary. The National Cancer Institute (NCI) launched the...
Thirty years ago, Mary-Claire King, PhD, FAACR, and colleagues were the first to demonstrate that breast cancer could be genetically inherited....
When creating anything new, one must ask the question, “will others use it?” A driving force behind the creation...